Related Experiment Videos
The epigenome as a molecular marker and target.
David Gius1, C Matthew Bradbury, Lunching Sun
1Molecular Radiation Oncology Section, Radiation Oncology Branch, Radiation Oncology Sciences Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1002, USA. giusd@mail.nih.gov
Cancer
|September 9, 2005
Summary
Methylation plays a key role in cancer development and progression. Further research into DNA methyltransferase (DNMT) genes could reveal new molecular markers and targets for anticancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Tumor progression involves complex mechanisms like altered cell cycle regulation, growth factor pathway activation, and reduced apoptosis.
- Epigenetic modifications, particularly DNA methylation, are increasingly recognized for their role in cellular transformation.
- Understanding these mechanisms is crucial for identifying novel therapeutic targets and improving cancer treatment strategies.
Purpose of the Study:
- To explore the central role of DNA methylation in cancer transformation.
- To investigate the potential of methylation-regulating genes as molecular markers for tumor profiling.
- To assess DNA methyltransferase (DNMT) genes as potential targets for novel anticancer agents.
Main Methods:
- Analysis of gene expression patterns related to methylation.
- Investigation of intracellular methyltransferase activity and its impact on gene expression.
- Examination of DNA methyltransferase (DNMT) genes for potential therapeutic applications.
Main Results:
- Methylation is confirmed to play a significant role in both in vitro and in vivo cancer transformation.
- The precise targets and mechanisms of methylation in cancer require further elucidation.
- Comprehensive methods for examining gene expression patterns are necessary for future research.
Conclusions:
- Genes regulating intracellular methylation status may serve as valuable molecular markers for tumor profiling.
- DNA methyltransferase (DNMT) genes represent promising novel molecular targets for developing targeted anticancer therapies.
- Further research into methylation's role in cancer is essential for advancing therapeutic interventions.